Enzon Pharmaceuticals's total assets for Q3 2023 were $47.00M, an increase of 0.70% from the previous quarter. ENZN total liabilities were $406.00K for the fiscal quarter, a 1.00% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.